Annual Accounts Payable
$10.27 M
+$5.54 M+117.04%
31 December 2023
Summary:
Castle Biosciences annual accounts payable is currently $10.27 million, with the most recent change of +$5.54 million (+117.04%) on 31 December 2023. During the last 3 years, it has risen by +$8.17 million (+389.42%). CSTL annual accounts payable is now at all-time high.CSTL Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$6.81 M
-$2.73 M-28.62%
30 September 2024
Summary:
Castle Biosciences quarterly accounts payable is currently $6.81 million, with the most recent change of -$2.73 million (-28.62%) on 30 September 2024. Over the past year, it has dropped by -$119.00 thousand (-1.72%). CSTL quarterly accounts payable is now -33.68% below its all-time high of $10.27 million, reached on 31 December 2023.CSTL Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSTL Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +117.0% | -1.7% |
| 3 y3 years | +389.4% | +146.2% |
| 5 y5 years | +607.6% | +444.2% |
CSTL Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +389.4% | -33.7% | +167.5% |
| 5 y | 5 years | at high | +607.6% | -33.7% | +444.2% |
| alltime | all time | at high | +819.5% | -33.7% | +444.2% |
Castle Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $6.81 M(-28.6%) |
| June 2024 | - | $9.54 M(+2.4%) |
| Mar 2024 | - | $9.32 M(-9.3%) |
| Dec 2023 | $10.27 M(+117.0%) | $10.27 M(+48.2%) |
| Sept 2023 | - | $6.93 M(-2.9%) |
| June 2023 | - | $7.13 M(-28.4%) |
| Mar 2023 | - | $9.96 M(+110.5%) |
| Dec 2022 | $4.73 M(+85.8%) | $4.73 M(-18.0%) |
| Sept 2022 | - | $5.77 M(+75.8%) |
| June 2022 | - | $3.28 M(-1.0%) |
| Mar 2022 | - | $3.31 M(+30.2%) |
| Dec 2021 | $2.55 M | $2.55 M(-8.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $2.77 M(+102.2%) |
| June 2021 | - | $1.37 M(-37.0%) |
| Mar 2021 | - | $2.17 M(+3.5%) |
| Dec 2020 | $2.10 M(+12.5%) | $2.10 M(-0.1%) |
| Sept 2020 | - | $2.10 M(-15.8%) |
| June 2020 | - | $2.50 M(+29.0%) |
| Mar 2020 | - | $1.93 M(+3.7%) |
| Dec 2019 | $1.86 M(+28.5%) | $1.86 M(+49.0%) |
| Sept 2019 | - | $1.25 M(-40.0%) |
| June 2019 | - | $2.08 M(+29.5%) |
| Mar 2019 | - | $1.61 M(+10.9%) |
| Dec 2018 | $1.45 M(+29.9%) | $1.45 M |
| Dec 2017 | $1.12 M | - |
FAQ
- What is Castle Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Castle Biosciences?
- What is Castle Biosciences annual accounts payable year-on-year change?
- What is Castle Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Castle Biosciences?
- What is Castle Biosciences quarterly accounts payable year-on-year change?
What is Castle Biosciences annual accounts payable?
The current annual accounts payable of CSTL is $10.27 M
What is the all time high annual accounts payable for Castle Biosciences?
Castle Biosciences all-time high annual accounts payable is $10.27 M
What is Castle Biosciences annual accounts payable year-on-year change?
Over the past year, CSTL annual accounts payable has changed by +$5.54 M (+117.04%)
What is Castle Biosciences quarterly accounts payable?
The current quarterly accounts payable of CSTL is $6.81 M
What is the all time high quarterly accounts payable for Castle Biosciences?
Castle Biosciences all-time high quarterly accounts payable is $10.27 M
What is Castle Biosciences quarterly accounts payable year-on-year change?
Over the past year, CSTL quarterly accounts payable has changed by -$119.00 K (-1.72%)